ReP USP - Resultado da busca

Trabalho de evento-resumo periodico
Identification of potent inhibitors of Zika and Dengue viruses proteases from smallmolecule compound libraries (2025)
Dolci, Isabela ; Cipriano, Lavinia; Noske, Gabriela Dias ; Godoy, Andre Schutzer de ; Fairhead, Michael; Fernandes, Rafaela Sachetto ; Oliva, Glaucius
Source: FEBS Open Bio. Conference titles: FEBS Congress. Unidade: IFSC
Subjects: ZIKA VÍRUS, DENGUE, BIOFÍSICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DOLCI, Isabela et al. Identification of potent inhibitors of Zika and Dengue viruses proteases from smallmolecule compound libraries. FEBS Open Bio. Oxford: Instituto de Física de São Carlos, Universidade de São Paulo. Disponível em: https://doi.org/10.1002/2211-5463.70071. Acesso em: 03 nov. 2025. , 2025
APA
Dolci, I., Cipriano, L., Noske, G. D., Godoy, A. S. de, Fairhead, M., Fernandes, R. S., & Oliva, G. (2025). Identification of potent inhibitors of Zika and Dengue viruses proteases from smallmolecule compound libraries. FEBS Open Bio. Oxford: Instituto de Física de São Carlos, Universidade de São Paulo. doi:10.1002/2211-5463.70071
NLM
Dolci I, Cipriano L, Noske GD, Godoy AS de, Fairhead M, Fernandes RS, Oliva G. Identification of potent inhibitors of Zika and Dengue viruses proteases from smallmolecule compound libraries [Internet]. FEBS Open Bio. 2025 ; 15 353.[citado 2025 nov. 03 ] Available from: https://doi.org/10.1002/2211-5463.70071
Vancouver
Dolci I, Cipriano L, Noske GD, Godoy AS de, Fairhead M, Fernandes RS, Oliva G. Identification of potent inhibitors of Zika and Dengue viruses proteases from smallmolecule compound libraries [Internet]. FEBS Open Bio. 2025 ; 15 353.[citado 2025 nov. 03 ] Available from: https://doi.org/10.1002/2211-5463.70071
Artigo de periodico
Combined crystallographic fragment screening and deep mutational scanning enable discovery of Zika virus NS2B-NS3 protease inhibitors (2025)
Ni, Xiaomin ; Godoy, Andre Schutzer de ; Dolci, Isabela ; Fernandes, Rafaela Sachetto ; Oliva, Glaucius
Source: Nature Communications. Unidade: IFSC
Subjects: ZIKA VÍRUS, VÍRUS, DENGUE, BIOFÍSICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NI, Xiaomin et al. Combined crystallographic fragment screening and deep mutational scanning enable discovery of Zika virus NS2B-NS3 protease inhibitors. Nature Communications, v. 16, p. 8930-1-8930-13 + supplementary information, 2025Tradução . . Disponível em: https://doi.org/10.1038/s41467-025-63602-z. Acesso em: 03 nov. 2025.
APA
Ni, X., Godoy, A. S. de, Dolci, I., Fernandes, R. S., & Oliva, G. (2025). Combined crystallographic fragment screening and deep mutational scanning enable discovery of Zika virus NS2B-NS3 protease inhibitors. Nature Communications, 16, 8930-1-8930-13 + supplementary information. doi:10.1038/s41467-025-63602-z
NLM
Ni X, Godoy AS de, Dolci I, Fernandes RS, Oliva G. Combined crystallographic fragment screening and deep mutational scanning enable discovery of Zika virus NS2B-NS3 protease inhibitors [Internet]. Nature Communications. 2025 ; 16 8930-1-8930-13 + supplementary information.[citado 2025 nov. 03 ] Available from: https://doi.org/10.1038/s41467-025-63602-z
Vancouver
Ni X, Godoy AS de, Dolci I, Fernandes RS, Oliva G. Combined crystallographic fragment screening and deep mutational scanning enable discovery of Zika virus NS2B-NS3 protease inhibitors [Internet]. Nature Communications. 2025 ; 16 8930-1-8930-13 + supplementary information.[citado 2025 nov. 03 ] Available from: https://doi.org/10.1038/s41467-025-63602-z
Artigo de periodico
How to find a fragment: methods for screening and validation in fragment-based drug discovery (2024)
Kirkman, Tim ; Silva, Catharina dos Santos ; Tosin, Manuela ; Dias, Marcio Vinicius Bertacine
Source: ChemMedChem: chemistry enabling drug. Unidade: ICB
Subjects: MICROBIOLOGIA, FÁRMACOS, MEDICAMENTO, TRIAGEM, BIOFÍSICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KIRKMAN, Tim et al. How to find a fragment: methods for screening and validation in fragment-based drug discovery. ChemMedChem: chemistry enabling drug, v. 19, n. 24, p. 14 , 2024Tradução . . Disponível em: https://doi.org/10.1002/cmdc.202400342. Acesso em: 03 nov. 2025.
APA
Kirkman, T., Silva, C. dos S., Tosin, M., & Dias, M. V. B. (2024). How to find a fragment: methods for screening and validation in fragment-based drug discovery. ChemMedChem: chemistry enabling drug, 19( 24), 14 . doi:10.1002/cmdc.202400342
NLM
Kirkman T, Silva C dos S, Tosin M, Dias MVB. How to find a fragment: methods for screening and validation in fragment-based drug discovery [Internet]. ChemMedChem: chemistry enabling drug. 2024 ; 19( 24): 14 .[citado 2025 nov. 03 ] Available from: https://doi.org/10.1002/cmdc.202400342
Vancouver
Kirkman T, Silva C dos S, Tosin M, Dias MVB. How to find a fragment: methods for screening and validation in fragment-based drug discovery [Internet]. ChemMedChem: chemistry enabling drug. 2024 ; 19( 24): 14 .[citado 2025 nov. 03 ] Available from: https://doi.org/10.1002/cmdc.202400342

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects